White Muscle Disease

White Muscle Disease is a nutritional muscle disorder in horses caused by deficiency of selenium, vitamin E, or both essential nutrients. The condition results in degeneration of skeletal and cardiac muscle fibers, which appear pale or white upon examination, giving the disease its descriptive name. White Muscle Disease represents one of the most significant nutritional disorders affecting equines, particularly in geographic regions where soils are naturally deficient in selenium, leading to selenium-poor forages and hay that fail to meet horses' nutritional requirements.

This condition most commonly affects young foals between birth and several months of age, though it can occur in horses of any age when nutritional deficiencies are severe or prolonged. Foals born to selenium-deficient mares are particularly vulnerable, as they enter life with inadequate selenium stores and continue nursing milk deficient in this essential trace mineral. Geographic distribution of White Muscle Disease correlates strongly with regional soil selenium content, with high incidence in the Pacific Northwest, Great Lakes region, and portions of the Atlantic Coast of the United States, as well as parts of Canada, New Zealand, and other areas with selenium-poor soils.

The impact of White Muscle Disease on equine health can be devastating, ranging from mild muscle weakness and stiffness to acute cardiac failure and death. The skeletal muscle form causes difficulty rising, standing, and nursing in foals, leading to weakness, starvation, and secondary complications. The cardiac form is particularly serious, causing sudden death from heart muscle degeneration without warning. Even surviving horses may develop chronic muscle damage affecting long-term athletic potential. The economic impact includes foal losses, veterinary treatment costs, and long-term performance limitations in affected horses.

White Muscle Disease is both preventable and treatable when recognized early, making awareness and proactive management essential. Prevention through appropriate selenium and vitamin E supplementation in deficient areas is straightforward and cost-effective. Early treatment with injectable selenium and vitamin E can reverse mild to moderate cases before permanent damage occurs. However, severe cases, particularly those involving cardiac muscle, carry guarded prognosis despite treatment. The key to successful management lies in recognizing regional risk, implementing preventive supplementation, and seeking immediate veterinary care when symptoms appear.

The primary cause of White Muscle Disease is nutritional deficiency of selenium, vitamin E, or both nutrients that serve essential antioxidant functions in muscle tissue. Selenium functions as a component of glutathione peroxidase, an enzyme that protects cell membranes from oxidative damage by neutralizing harmful peroxides produced during normal cellular metabolism. Vitamin E acts as a lipid-soluble antioxidant directly protecting cell membrane fatty acids from oxidative destruction. When either or both nutrients are deficient, muscle cells accumulate oxidative damage that triggers degeneration and necrosis of muscle fibers.

Geographic factors determine selenium availability in forage, creating regional patterns of White Muscle Disease prevalence. Selenium enters the food chain through plant uptake from soil, and soils formed from certain parent materials or heavily leached by rainfall contain inadequate selenium. The Pacific Northwest region of North America is notorious for selenium-deficient soils, as are glaciated regions of the Great Lakes and Northeast. Horses relying primarily on locally grown hay and pasture in these regions receive inadequate dietary selenium unless supplementation is provided. Imported hay from selenium-adequate regions may not be identified as such, complicating dietary assessment.

Environmental and management factors influence White Muscle Disease risk beyond simple geographic location. Horses maintained exclusively on local hay and pasture without supplemental feeds or minerals face highest risk. High-sulfur water or feed interferes with selenium absorption, increasing deficiency risk even when dietary selenium appears adequate. Pregnant and lactating mares have elevated selenium requirements, and deficiency during gestation depletes fetal selenium stores. Foals nursing selenium-deficient mares receive insufficient selenium through milk to meet their high growth demands. Stress, illness, and intensive exercise increase oxidative load, potentially precipitating clinical disease in marginally deficient horses.

Risk factors for developing White Muscle Disease include young age, geographic location, feeding practices, and maternal nutritional status. Neonatal foals are most vulnerable due to limited selenium stores at birth and rapid growth rates. Pregnant mares in selenium-deficient regions transfer this deficiency to developing foals. Horses fed exclusively home-grown hay without mineral supplementation in deficient regions face cumulative risk. Performance horses with high oxidative demands may develop deficiency despite adequate intake for maintenance horses. Failure to recognize regional selenium status leads to continued deficiency across breeding programs.

The pathophysiology of White Muscle Disease involves progressive oxidative destruction of muscle cell membranes. Without adequate selenium-dependent glutathione peroxidase and vitamin E, reactive oxygen species produced during normal muscle metabolism damage cellular structures. Membrane damage leads to calcium influx into cells, activating destructive enzymes and triggering cell death. Damaged muscle fibers undergo coagulative necrosis, appearing pale or white on gross examination due to loss of myoglobin. Cardiac muscle involvement causes arrhythmias and heart failure. Skeletal muscle damage causes weakness, stiffness, and inability to perform normal movements.

Early warning signs of White Muscle Disease in foals may be subtle and easily attributed to other causes of neonatal weakness. Affected foals often appear normal at birth but develop progressive weakness over the first days to weeks of life. Early signs include mild stiffness when rising, hesitation before nursing, and slightly shortened stride length. Foals may tire quickly during nursing and require frequent rest periods. Reduced vigor and playfulness compared to normal foals indicates potential problems. Mare owners should monitor foaling closely in selenium-deficient regions and seek veterinary evaluation for any foal weakness.

Common symptoms of the skeletal muscle form of White Muscle Disease include progressive weakness, stiffness, and difficulty with normal movements. Affected foals struggle to rise from recumbency and may require assistance. Once standing, they display a stiff, stilted gait with shortened stride length and arched back. Muscle trembling, particularly in the hindquarters and along the topline, becomes visible during standing and movement. Swallowing difficulty may develop when tongue and throat muscles are affected, leading to aspiration pneumonia as a dangerous complication. Respiratory difficulty occurs when chest wall muscles degenerate.

Behavioral changes in horses with White Muscle Disease reflect generalized weakness and discomfort. Foals become reluctant to nurse due to weakness and swallowing difficulty, leading to dehydration and hypoglycemia that compound the primary problem. Affected foals lie down frequently and for extended periods, reducing activity below normal newborn behavior. Depression and reduced responsiveness develop as weakness progresses. Adult horses may show reluctance to exercise, early fatigue during work, and general malaise. Performance horses demonstrate unexplained reduction in athletic capacity before other symptoms become apparent.

Physical signs beyond obvious weakness provide diagnostic clues for White Muscle Disease. Muscle swelling occurs in affected areas during the acute phase, followed by atrophy as degeneration progresses. Muscles feel firm and painful on palpation during active degeneration. Dark or coffee-colored urine indicates myoglobin release from damaged muscles, a serious sign warranting immediate veterinary attention. Elevated heart rate and respiratory rate reflect both cardiac involvement and the stress of struggling with weakness. Poor body condition develops rapidly in foals unable to nurse adequately.

Symptom progression in untreated White Muscle Disease follows a deteriorating course. Mild weakness progresses to inability to stand without assistance. Nursing becomes impossible as weakness advances, leading to starvation and dehydration. Respiratory muscle weakness causes breathing difficulty and predisposes to aspiration pneumonia. Recumbent foals develop pressure sores and secondary complications from inability to move. Without treatment, progressive deterioration leads to death from cardiac failure, respiratory failure, or secondary complications within days to weeks of symptom onset.

Emergency symptoms requiring immediate veterinary intervention include any foal unable to rise or nurse, visible difficulty breathing, dark discolored urine, signs of cardiac distress including weak pulse and pale gums, or sudden collapse. The cardiac form of White Muscle Disease may present with sudden death without prior symptoms, making prevention critically important. Any foal in a selenium-deficient region showing weakness should receive emergency veterinary evaluation. Adult horses showing myoglobinuria or signs of acute muscle damage also require immediate care.

Physical examination of horses suspected of White Muscle Disease reveals findings consistent with muscle weakness and damage. Foals demonstrate difficulty rising, stiff gait, and generalized weakness. Muscle palpation may reveal firm, swollen, painful muscles during acute phases or atrophied muscles in chronic cases. Cardiac auscultation may detect arrhythmias or abnormal heart sounds indicating cardiac muscle involvement. Respiratory rate and effort assessment identifies respiratory muscle weakness. Neurological examination helps distinguish White Muscle Disease from neurological causes of weakness. Body condition assessment evaluates nutritional status and secondary complications.

Blood work provides essential diagnostic information confirming muscle damage and evaluating severity. Serum muscle enzymes including creatine kinase (CK) and aspartate aminotransferase (AST) are markedly elevated during active muscle degeneration, often reaching values many times normal. Lactate dehydrogenase (LDH) elevation provides additional evidence of tissue damage. Selenium blood levels confirm deficiency, with whole blood selenium being more accurate than serum values. Vitamin E levels should also be assessed, as deficiency of either nutrient can cause disease. Complete blood count identifies secondary complications including dehydration and infection.

Advanced diagnostics provide additional information in complex cases. Urinalysis confirms myoglobinuria when dark urine is present. Electrocardiography (ECG) evaluates cardiac rhythm and identifies arrhythmias from cardiac muscle damage. Echocardiography visualizes heart structure and function, detecting cardiomyopathy. Muscle biopsy, while rarely necessary for diagnosis, provides definitive confirmation through characteristic histopathological findings of muscle fiber degeneration and necrosis. Regional soil and forage selenium testing helps establish environmental risk factors for herd-level management.

Differential diagnosis requires distinguishing White Muscle Disease from other causes of weakness and muscle dysfunction in foals and horses. Neonatal maladjustment syndrome causes weakness in newborn foals but without elevated muscle enzymes. Septicemia produces systemic illness with weakness but different laboratory findings. Botulism causes flaccid paralysis requiring differentiation. Other myopathies including polysaccharide storage myopathy have different underlying mechanisms and blood selenium levels are normal. Hypothyroidism can cause muscle weakness in foals. Physical injury or fractures may present with similar reluctance to move. Careful physical examination, blood work, and history of regional selenium status guide accurate diagnosis.

Emergency treatment for acute White Muscle Disease focuses on replacing deficient nutrients and providing supportive care for affected horses. Injectable selenium and vitamin E supplementation provides rapid restoration of these essential nutrients. The combination product selenium and vitamin E (commonly branded as Bo-Se or similar) is administered according to body weight under veterinary supervision. Selenium has a narrow safety margin, making accurate dosing critical to avoid toxicity. Severely affected foals require hospitalization for intensive monitoring and support. Cardiac monitoring is essential due to arrhythmia risk.

Medical management continues beyond initial emergency treatment with ongoing supplementation and supportive care. Oral vitamin E supplementation provides sustained antioxidant support during recovery. Selenium supplementation continues orally after initial injection, with careful attention to avoiding excess. Anti-inflammatory medications may provide comfort during the recovery phase. Antibiotics treat secondary infections including aspiration pneumonia that commonly complicates swallowing difficulty. Gastric ulcer prophylaxis prevents stress ulceration in hospitalized foals. Fluid therapy corrects dehydration in foals unable to nurse adequately.

Surgical intervention is not applicable for White Muscle Disease treatment, as this condition requires nutritional and medical management rather than surgical correction. However, supportive procedures may be necessary for complications. Nasogastric tube feeding provides nutrition for foals unable to nurse. Urinary catheterization may be needed for recumbent horses. Tracheostomy is rarely required for severe respiratory compromise. These interventions address complications rather than the primary disease process.

Supportive care during recovery emphasizes nutrition, nursing support, and physical assistance. Foals unable to nurse require bottle feeding or nasogastric nutrition with mare's milk or appropriate milk replacer. Assisted standing helps maintain muscle function and prevents recumbency complications. Deep bedding protects recumbent foals from pressure sores. Temperature support prevents hypothermia in weak foals. Turning recumbent horses every few hours prevents muscle damage and respiratory complications. Physical therapy including passive range of motion exercises maintains joint mobility during recovery.

Rehabilitation and return to normal activity follow muscle recovery timelines that vary based on damage severity. Mild cases may recover within one to two weeks with appropriate treatment. Moderate cases require several weeks to months for muscle regeneration. Exercise begins with short periods of hand-walking, gradually increasing as strength returns. Nutritional supplementation continues through recovery and as ongoing prevention. Monitoring muscle enzymes guides activity progression. Cardiac evaluation before return to athletic work ensures heart function recovery in horses with cardiac involvement.

Treatment decisions consider disease severity, cardiac involvement, and resources available for intensive care. Mild skeletal muscle disease responds well to outpatient treatment with excellent prognosis. Moderate disease may benefit from short hospitalization for intensive support. Severe skeletal disease requires extended intensive care with guarded prognosis. Significant cardiac involvement carries poor prognosis even with aggressive treatment. Economic considerations for extended hospitalization factor into treatment planning. Humane euthanasia may be appropriate for severely affected horses with poor prognosis despite treatment.

Recovery timeline for White Muscle Disease varies dramatically based on severity and which muscle groups are affected. Mild cases involving limited skeletal muscle damage may show improvement within days of starting selenium and vitamin E supplementation, with full recovery occurring over one to three weeks. Moderate cases require several weeks to months for muscle fiber regeneration and restoration of normal strength. Severe cases with extensive skeletal muscle involvement need months of recovery time and may retain permanent deficits. Cardiac muscle recovery is particularly concerning, as heart muscle has limited regenerative capacity, and damage may be permanent.

Post-treatment care and monitoring extend well beyond initial recovery. Ongoing selenium and vitamin E supplementation prevents recurrence, particularly in horses remaining in deficient regions. Serial muscle enzyme monitoring confirms continued recovery and detects any setbacks. Body condition monitoring ensures adequate nutrition during the recovery phase. Activity logs document progressive return to normal function. Cardiac monitoring in horses with initial cardiac involvement should continue periodically to detect delayed complications. Foals recovering from White Muscle Disease need monitoring throughout their growth period.

Prognosis factors influencing outcomes include age at onset, severity of muscle damage, cardiac involvement, promptness of treatment, and response to initial therapy. Foals diagnosed early with mild disease achieve excellent outcomes. Severe skeletal muscle disease carries guarded prognosis with potential for permanent weakness. Any cardiac involvement significantly worsens prognosis due to limited heart muscle regeneration. Foals that remain standing throughout treatment fare better than those becoming recumbent. Response to treatment within the first forty-eight to seventy-two hours provides prognostic information, with improvement indicating favorable outcome likelihood.

Long-term soundness outlook for horses surviving White Muscle Disease depends on residual muscle damage. Many horses recover completely and achieve full athletic potential when treated early and effectively. Horses with extensive skeletal muscle damage may retain chronic weakness or reduced exercise tolerance. Cardiac damage may limit athletic capacity or predispose to exercise-induced arrhythmias. Performance expectations should be adjusted based on recovery assessment, with some horses suitable only for light use. Long-term cardiac monitoring is advisable for horses with documented cardiac involvement during acute illness.

Management practices preventing White Muscle Disease center on awareness of regional selenium status and appropriate supplementation strategies. Horse owners should determine whether their region is selenium-deficient through consultation with local veterinarians, agricultural extension services, or soil testing. Recognizing that locally produced hay and pasture in deficient regions will not meet selenium requirements is essential for prevention planning. All horses in deficient areas require supplementation regardless of apparent health status. Breeding programs should implement selenium protocols for all mares and foals.

Nutritional prevention through appropriate selenium and vitamin E supplementation is straightforward and highly effective. Commercial feeds formulated for horses typically contain added selenium and vitamin E. Trace mineral supplements specifically designed for selenium-deficient regions provide concentrated supplementation. Salt blocks containing selenium offer free-choice supplementation, though intake variation limits reliability. Injectable selenium administered to pregnant mares during the last month of gestation ensures adequate selenium transfer to foals. Foals in deficient regions should receive selenium supplementation according to veterinary guidance.

Supplementation guidelines must balance adequacy against toxicity, as selenium has a narrow safety margin. The National Research Council recommends 0.1 mg selenium per kilogram of diet dry matter for horses. Maximum tolerable concentration is 2 mg per kilogram, above which chronic toxicity may develop. Supplementation programs should calculate total selenium intake from all sources including feed, supplements, and forages. Blood selenium monitoring every six to twelve months confirms appropriate supplementation levels. Veterinary consultation helps design safe, effective supplementation programs for specific situations.

Environmental factors influencing prevention strategies include soil selenium content, water quality, and pasture management. Soil testing identifies selenium levels, though plant uptake varies with soil pH and plant species. Fertilization with selenium-containing products can improve pasture selenium content in some situations. Water high in sulfur reduces selenium absorption, requiring increased supplementation. Importing hay from selenium-adequate regions can contribute to meeting requirements. Careful record-keeping of all selenium sources prevents inadvertent over- or under-supplementation.

Breeding program management in deficient regions requires particular attention to mare supplementation. Selenium crosses the placenta and appears in milk, making mare status critical for foal health. Injectable selenium during late gestation ensures adequate fetal selenium stores at birth. Continuing mare supplementation during lactation provides selenium through milk. Foals should receive selenium supplementation beginning in the first weeks of life in deficient regions. Breeding stock selection does not influence disease susceptibility, as White Muscle Disease is nutritional rather than genetic in origin.

Daily management for horses in selenium-deficient regions incorporates consistent supplementation as routine practice. Selenium-containing trace mineral supplements should be offered daily through grain meals or free-choice mineral feeders. Commercial feeds with guaranteed selenium content simplify meeting requirements when fed according to label directions. Water availability and consumption should be monitored, as adequate hydration supports overall health. Daily observation for any signs of weakness, stiffness, or reduced activity allows early detection of developing problems. Records of supplementation help ensure consistent provision.

Housing and turnout considerations for horses at risk of selenium deficiency include recognition that pasture provides minimal selenium in deficient regions. Horses on pasture-only diets require supplementation through mineral feeders or periodic oral dosing. Stalled horses receiving grain meals have easier supplementation through feed additives. Group feeding situations may result in uneven supplement intake, requiring monitoring of individual horses. Foaling mares should be housed where supplementation can be closely managed and newborn foals can be monitored for signs of weakness.

Exercise modifications are primarily relevant during recovery from White Muscle Disease rather than for prevention. Horses recovering from muscle damage should begin with limited activity, gradually increasing exercise as strength returns. Work intensity should match recovery status, with mild exercise supporting rehabilitation without causing additional muscle damage. Monitoring for early fatigue, muscle stiffness, or reluctance to work guides activity adjustments. Performance horses returning from White Muscle Disease require gradual conditioning before resuming competitive work. Cardiac evaluation should clear horses with previous cardiac involvement before strenuous exercise.

Monitoring and ongoing care requirements include periodic blood selenium testing to verify supplementation adequacy. Annual or semi-annual selenium level assessment ensures long-term prevention success. Veterinary wellness examinations provide opportunities to review supplementation programs. New horses entering a selenium-deficient property should be tested and supplementation adjusted as needed. Changes in feed sources require reassessment of total selenium intake. Foals should be monitored closely during their first weeks and months for any signs of muscle weakness.

Quality of life considerations for horses in selenium-deficient regions emphasize that prevention allows entirely normal lives. Properly supplemented horses face no limitations from regional selenium status. The minimal cost and effort of appropriate supplementation prevents a devastating but entirely avoidable disease. Horses recovered from White Muscle Disease may achieve full quality of life with ongoing supplementation, though those with permanent damage may require activity modifications. The straightforward preventability of this condition makes owner education and awareness the most critical factors in protecting horse health in deficient regions.

White Muscle Disease affects all horse breeds equally, as susceptibility depends entirely on nutritional selenium and vitamin E status rather than genetic factors. No breed-specific predisposition exists for this nutritional deficiency disease. The condition is reported across Thoroughbreds, Quarter Horses, Arabians, Warmbloods, draft breeds, ponies, and all other equine breeds when dietary deficiencies occur. Geographic location and management practices determine risk far more than breed characteristics.

Certain use categories face elevated risk based on management practices rather than breed affiliation. Horses maintained exclusively on locally produced hay and pasture in selenium-deficient regions, regardless of breed, face the highest risk. Pregnant and lactating mares have increased selenium requirements, making deficiency more likely and consequences more severe through effects on foals. Performance horses with high oxidative demands from intensive training may develop clinical disease at selenium levels adequate for maintenance horses. Young, growing horses have heightened requirements that may not be met by adult maintenance diets.

Genetic testing is not applicable for White Muscle Disease, as no genetic component influences susceptibility. Breeding recommendations focus on nutritional management rather than selection criteria. Mares in deficient regions should receive appropriate selenium supplementation throughout pregnancy to protect developing foals. Stallion selenium status does not directly influence offspring susceptibility, though overall breeding program management should include attention to mare nutrition. Selection against White Muscle Disease susceptibility is not possible because the condition is entirely nutritional in origin, making prevention through appropriate supplementation the only management approach.

Equine Motor Neuron Disease (EMND) represents a related condition also caused by vitamin E deficiency, though with different clinical presentation and affected tissues. EMND causes progressive neurological dysfunction from motor neuron degeneration rather than primary muscle disease. Both conditions respond to vitamin E supplementation, and combined selenium and vitamin E deficiency may contribute to EMND development. Horses in deficient regions should receive both nutrients to prevent the spectrum of deficiency-related diseases. Long-term vitamin E deficiency may cause EMND even when selenium status is adequate.

Conditions with similar symptoms requiring differentiation include various causes of foal weakness and muscle dysfunction. Neonatal maladjustment syndrome (dummy foal syndrome) causes weakness but results from hypoxic brain injury rather than muscle disease. Septicemia produces systemic illness with weakness requiring different treatment. Botulism causes rapidly progressive paralysis with characteristic signs distinguishing it from White Muscle Disease. Polysaccharide storage myopathy in adult horses causes exercise-associated muscle dysfunction with normal selenium levels. Hypothyroidism in foals causes weakness and poor development. Careful diagnostic evaluation distinguishes these conditions from nutritional myodegeneration.

Potential complications from White Muscle Disease include secondary problems arising during illness and long-term consequences of muscle damage. Aspiration pneumonia develops when swallowing muscle weakness causes inhalation of milk or food, representing a serious and potentially fatal complication. Pressure sores and secondary muscle damage occur in recumbent foals unable to shift position. Cardiac arrhythmias and heart failure result from cardiac muscle involvement. Chronic weakness may persist following severe skeletal muscle damage. Growth retardation may affect foals whose nutrition was compromised during critical developmental periods.